ArticleFrontiers in pharmacology2023

2D, 3D-QSAR study and docking of vascular endothelial growth factor receptor 3 (VEGFR3) inhibitors for potential treatment of retinoblastoma.

Rui Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.